K7M2 wt [K7M2-WT] (小鼠骨肉瘤成骨细胞) (STR鉴定正确)

一键复制产品信息

参考文献

• A bone-targeting permeable nanomicelle acting as an icebreaker for enhancing chemotherapy of osteosarcoma (2024-03-29)

  作者：Bowen Duan: 1.NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, Department of Pharmaceutics, China Pharmaceutical University 24 Tong Jia Xiang, Nanjing 210009, China; Hongting Liu: 1.NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, Department of Pharmaceutics, China Pharmaceutical University 24 Tong Jia Xiang, Nanjing 210009, China; Xiaoxuan Ji: 1.NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, Department of Pharmaceutics, China Pharmaceutical University 24 Tong Jia Xiang, Nanjing 210009, China; Jingwen Dong: 1.NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, Department of Pharmaceutics, China Pharmaceutical University 24 Tong Jia Xiang, Nanjing 210009, China; Xinping Luo: 1.NMPA Key Laboratory for Research and Evaluation of Pharmaceutical Preparations and Excipients, Department of Pharmaceutics, China Ph

  期刊：A bone-targeting permeable nanomicelle acting as an icebreaker for enhancing chemotherapy of osteosarcoma

  DOI：10.1016/j.cej.2024.150821

  影响因子 ：15.1

  引用产品： K7M2 wt [K7M2-WT] 细胞

• Investigating the synergy of Shikonin and Valproic acid in inducing apoptosis of osteosarcoma cells via ROS-mediated EGR1 expression (2024-02-15)

  作者：Zhuo Chen:1.The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China; Huzhou Central Hospital, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang, PR China. ; Feng-Feng Wu:1.Huzhou Central Hospital, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang, PR China; The Fifth School of Clinical Medicine of Zhejiang Chinese Medical University, Huzhou, Zhejiang, PR China; The Affiliated Central Hospital, Huzhou University, Huzhou, Zhejiang, PR China; Huzhou Basic and Clinical Translation of Orthopaedics Key Laboratory, Huzhou, Zhejiang, PR China. ; Jing Li:1.School of Medicine, Huzhou University, Huzhou, Zhejiang, PR China. ; Jia-Bao Dong:1.The Second Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang, PR China; Huzhou Central Hospital, Affiliated Huzhou Hospital, Zhejiang University School of Medicine, Huzhou, Zhejiang, PR China. ; Hong-Yi He:1.Schoo

  期刊：Investigating the synergy of Shikonin and Valproic acid in inducing apoptosis of osteosarcoma cells via ROS-mediated EGR1 expression

  DOI：10.1016/j.phymed.2024.155459

  影响因子 ：7.9

  引用产品： HOS 细胞 ,  K7M2 wt [K7M2-WT] 细胞 ,  DMEM高糖 培养基

• Injectable thermosensitive black phosphorus nanosheet- and doxorubicin-loaded hydrogel for synergistic bone tumor photothermal-chemotherapy and osteogenesis enhancement (2023-03-25)

  作者：Shihuai Li:1.Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China. ; Yunan Qing:1.Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China. ; Yan Lou:1.Department of Nephropathy, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China. ; Ruiyan Li:1.Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China. ; Hao Wang:1.Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China. ; Xingyue Wang:1.Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China. ; Boda Ying:1.Orthopaedic Medical Center, The Second Hospital of Jilin University, Changchun 130041, People's Republic of China. ; Xiongfeng Tang:1.Orthopaedic Medical Center, The Second Hospital of Jilin University, Cha

  期刊：Injectable thermosensitive black phosphorus nanosheet- and doxorubicin-loaded hydrogel for synergistic bone tumor photothermal-chemotherapy and osteogenesis enhancement

  DOI：10.1016/j.ijbiomac.2023.124209

  影响因子 ：8.2

  引用产品： MC3T3-E1 Subclone 24 细胞 ,  人脐静脉内皮细胞 ,  NCTC clone 929 [L 细胞, L-929] 细胞 ,  K7M2 wt [K7M2-WT] 细胞

• Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1–3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment (2023-06-08)

  作者：Song Liao:1.Medical School of Chinese PLA, Beijing, China. ; 2.Senior Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China. ; Jianxiong Li:1.Medical School of Chinese PLA, Beijing, China. ; 2.Senior Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China. ; Song Gao:1.Senior Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China. ; Yuchen Han:1.Medical School of Chinese PLA, Beijing, China. ; 2.Senior Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China. ; Xinli Han:1.Senior Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China. ; Yanan Wu:1.Medical School of Chinese PLA, Beijing, China. ; 2.Senior Department of Orthopedics, The Fourth Medical Center, Chinese PLA General Hospital, Beijing, China. ; Jingyou Bi:1.Medical School of Chinese PLA, Beijing, China. ;

  期刊：Sulfatinib, a novel multi-targeted tyrosine kinase inhibitor of FGFR1, CSF1R, and VEGFR1–3, suppresses osteosarcoma proliferation and invasion via dual role in tumor cells and tumor microenvironment

  DOI：10.3389/fonc.2023.1158857

  影响因子 ：4.7

  引用产品： MG-63 细胞 ,  U-2 OS [U2OS] 细胞 ,  HOS 细胞 ,  K7M2 wt [K7M2-WT] 细胞 ,  RAW 264.7 细胞

• LPS combined with CD47mAb enhances the anti‑osteosarcoma ability of macrophages (2023-03-28)

  作者：Peng Yuan:1.Department of Orthopedics, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, P.R. China. ; 2.Department of Orthopedics, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230000, P.R. China. ; Yukang Que:1.Department of Orthopedics, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, P.R. China. ; Yulei Liu:1.Department of Orthopedics, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, P.R. China. ; 2.Department of Orthopedics, The First Affiliated Hospital of Anhui Medical University, Hefei, Anhui 230000, P.R. China. ; Peng He:1.Department of Orthopedics, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, P.R. China. ; Zehao Guo:1.Department of Orthopedics, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, P.R. China. ; Yong Hu:1.Department of Orthopedics, Fuyang Hospital of Anhui Medical University, Fuyang, Anhui 236000, P.R. China. ; 2.Department of Orthopedics, The

  期刊：LPS combined with CD47mAb enhances the anti‑osteosarcoma ability of macrophages

  DOI：10.3892/ol.2023.13777

  影响因子 ：2.9

  引用产品： RAW 264.7 细胞 ,  K7M2 wt [K7M2-WT] 细胞 ,  U-2 OS [U2OS] 细胞 ,  MG-63 细胞

• Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells (2005-02-20)

  作者：Qingxin Fan:1.Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region (Hospital.C.T.), Sichuan University, Chengdu, 610041, China. ; 2.State Key Laboratory of Biotherapy and Cancer Center, Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu, 610041, China. ; 3.Department of Orthopedics, Hospital of Chengdu Office of People's Government of TibetanAutonomous Region (Hospital.C.T.), Orthopedic Research Institute, West China Hospital, Sichuan University, Chengdu, 610041, China. ; Jing Zuo:1.Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region (Hospital.C.T.), Sichuan University, Chengdu, 610041, China. ; 2.State Key Laboratory of Biotherapy and Cancer Center, Collaborative Innovation Center for Biotherapy, Sichuan University, Chengdu, 610041, China. ; Hailong Tian:1.Hospital of Chengdu Office of People's Government of Tibetan Autonomous Region (Hospital.C.T.), Sichuan University, Chengdu, 610041, China. ; 2.State Ke

  期刊：Nanoengineering a metal–organic framework for osteosarcoma chemo-immunotherapy by modulating indoleamine-2,3-dioxygenase and myeloid-derived suppressor cells

  DOI：10.1186/s13046-022-02372-8

  影响因子 ：11.3

  引用产品： K7M2 wt [K7M2-WT] 细胞

• MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression (2001-02-20)

  作者：Jinti Lin:1.Department of Orthopedics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, PR China. ; 2.Orthopedics Research Institute， Zhejiang University, Hangzhou, PR China. ; Ankai Xu:1.Department of Orthopedics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, PR China. ; 2.Orthopedics Research Institute， Zhejiang University, Hangzhou, PR China. ; Jiakang Jin:1.Department of Orthopedics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, PR China. ; 2.Orthopedics Research Institute， Zhejiang University, Hangzhou, PR China. ; Man Zhang:1.Department of Orthopedics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, PR China. ; 2.Orthopedics Research Institute， Zhejiang University, Hangzhou, PR China. ; Jianan Lou:1.Department of Orthopedics, The Second Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, PR China. ; 2.Orthopedi

  期刊：MerTK-mediated efferocytosis promotes immune tolerance and tumor progression in osteosarcoma through enhancing M2 polarization and PD-L1 expression

  DOI：10.1080/2162402X.2021.2024941

  影响因子 ：7.2

  引用产品： RAW 264.7 细胞 ,  K7M2 wt [K7M2-WT] 细胞 ,  NIH/3T3 细胞 ,  293T [HEK-293T] 细胞

• Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy (2022-02-11)

  作者：Peng He:1.Department of Orthopedics, First Affiliated Hospital of Anhui Medical University, Hefei, China. ; Shenglin Xu:1.Department of Orthopedics, First Affiliated Hospital of Anhui Medical University, Hefei, China. ; Zehao Guo:1.Department of Orthopedics, First Affiliated Hospital of Anhui Medical University, Hefei, China. ; Peng Yuan:1.Department of Orthopedics, Fuyang Hospital of Anhui Medical University, Fuyang, China. ; Yulei Liu:1.Department of Orthopedics, Fuyang Hospital of Anhui Medical University, Fuyang, China. ; Yu Chen:1.Department of Pharmacy, Anqing Medical College, Anqing, China. ; Tiantian Zhang:1.Laboratory of Pharmaceutical Research, Anhui Zhongren Science and Technology Co., Ltd, Hefei, China. ; Yukang Que:1.Department of Orthopedics, First Affiliated Hospital of Anhui Medical University, Hefei, China. ; Yong Hu:1.Department of Orthopedics, First Affiliated Hospital of Anhui Medical University, Hefei, China. ;

  期刊：Pharmacodynamics and pharmacokinetics of PLGA-based doxorubicin-loaded implants for tumor therapy

  DOI：10.1080/10717544.2022.2032878

  影响因子 ：6.0

  引用产品： K7M2 wt [K7M2-WT] 细胞

点击展开收起列表